METTL3-mediated m6A modification of SLC7A11 enhances nasopharyngeal carcinoma radioresistance by inhibiting ferroptosis
International Journal of Biological Sciences · 10.02.2025 · 21 (4) · 1837-1851
DOI: 10.7150/ijbs.100518 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Biological Sciences, erschienen am 10.02.2025. Verfasst von Zili Dai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical University, Guangzhou 510…. Hauptthemen laut MEDLINE: Ferroptosis, Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms, Amino Acid Transport System y+. Die Arbeit wurde bisher 35-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Radiotherapy is the primary treatment for nasopharyngeal carcinoma (NPC); nonetheless, radioresistance remains the leading cause of localized recurrence. Our study demonstrates a significant increase in the N6-methyladenosine (m6A) methylase METTL3 in NPC and other tumors. Mechanistically, METTL3 acts as an m6A methylase, enhancing the m6A modification of the solute carrier family 7 member 11 (SLC7A11) transcript, which increases its stability and expression, thereby inhibiting radiation-induced ferroptosis and ultimately inducing radioresistance in NPC. Furthermore, silencing SLC7A11 or employing the ferroptosis inducer Erastin negated the promoting effect of METTL3 on NPC cell radioresistance. These findings suggest that METTL3 could be a novel therapeutic target for overcoming radiotherapy resistance in NPC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical University, Guangzhou 510095, China.
- Department of pathology, Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical University, Guangzhou, China.
- Department of Thoracic Surgery, Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical University, Guangzhou, China.
Zitieren
APA
Dai, Z., Lin, B., Qin, M., Lin, Y., Wang, L., Liao, K., Xie, G., Wang, F., & Zhang, J. (2025). METTL3-mediated m6A modification of SLC7A11 enhances nasopharyngeal carcinoma radioresistance by inhibiting ferroptosis. International Journal of Biological Sciences, 21(4), 1837-1851. https://doi.org/10.7150/ijbs.100518
Vancouver
Dai Z, Lin B, Qin M, Lin Y, Wang L, Liao K, et al. METTL3-mediated m6A modification of SLC7A11 enhances nasopharyngeal carcinoma radioresistance by inhibiting ferroptosis. International Journal of Biological Sciences. 2025;21(4):1837-1851. doi:10.7150/ijbs.100518
BibTeX
@article{Dai2025,
author = {Dai, Zili and Lin, Baisheng and Qin, Maohua and Lin, Yunen and Wang, Li and Liao, Kai and Xie, Guofeng and Wang, Feixiang and Zhang, Jian},
title = {METTL3-mediated m6A modification of SLC7A11 enhances nasopharyngeal carcinoma radioresistance by inhibiting ferroptosis},
journal = {International Journal of Biological Sciences},
year = {2025},
volume = {21},
number = {4},
pages = {1837--1851},
doi = {10.7150/ijbs.100518}
}
EUVIMED